Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hirth, R. A.
Right arrow Articles by Weissert, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirth, R. A.
Right arrow Articles by Weissert, W. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Other

Willingness to Pay for a Quality-adjusted Life Year

In Search of a Standard

Richard A. Hirth, PhD

Michael E. Chernew, PhD

Edward Miller, MA

A. Mark Fendrick, MD

William G. Weissert, PhD

Cost-benefit analysis (CBA) provides a clear decision rule: undertake an intervention if the monetary value of its benefits exceed its costs. However, due to a reluctance to characterize health benefits in monetary terms, users of cost-utility and cost-effectiveness analyses must rely on arbitrary standards (e.g., < $50,000 per QALY) to deem a program "cost-effective." Moreover, there is no consensus regarding the appropriate dollar value per QALY gained upon which to base resource allocation decisions. To address this, the authors determined the value of a QALY as implied by the value-of-life literature and compared this value with arbitrary thresholds for cost-effectiveness that have come into common use. A literature search identified 42 estimates of the value of life that were appropriate for inclusion. These estimates were classified by method: human capital (HK), contingent valuation (CV), revealed preference/job risk (RP-JR) and revealed preference/non-occupational safety (RP-S), and by U.S. or non-U.S. origin. After converting these value-of-life estimates to 1997 U.S. dollars, the life expectancy of the study population, age-specific QALY weights, and a 3% real discount rate were used to calculate the implied value of a QALY. An ordinary least-squares regression of the value of a QALY on study type and national origin explained 28.4% of the variance across studies. Most of the explained variance was attributable to study type; national origin did not significantly affect the values. Median values by study type were $24,777 (HK estimates), $93,402 (RP-S estimates), $161,305 (CV estimates), and $428,286 (RP-JR estimates). With the exception of HK, these far exceed the "rules of thumb" that are frequently used to determine whether an intervention produces an acceptable increase in health benefits in exchange for incremental expenditures. Key words: cost-effectiveness analysis; cost-utility analysis; quality-adjusted life years; value of life. (Med Decis Making 2000;20:332-342)

Medical Decision Making, Vol. 20, No. 3, 332-342 (2000)
DOI: 10.1177/0272989X0002000310
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
A. A.A. Fiddelers, C. D. Dirksen, J. C.M. Dumoulin, A. P.A. van Montfoort, J. A. Land, J. M. Janssen, J. L.H. Evers, and J. L. Severens
Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model
Hum. Reprod., July 1, 2009; 24(7): 1648 - 1655.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
C. G. Cameron MSc and H. A. Bennett BPharm PhD
Cost-effectiveness of insulin analogues for diabetes mellitus
Can. Med. Assoc. J., February 17, 2009; 180(4): 400 - 407.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. Towse
Should NICE's threshold range for cost per QALY be raised? Yes
BMJ, January 26, 2009; 338(jan26_2): b181 - b181.
[Full Text]

Home page
 Med Decis MakingHome page
J. Y. Chen, S. Swonger, G. Kominski, Honghu Liu, Ji Eun Lee, and A. Diamant
Cost-Effectiveness of Insuring the Uninsured: The Case of Korean American Children
Med Decis Making, January 1, 2009; 29(1): 51 - 60.
[Abstract] [PDF]

Home page
 Health Aff (Millwood)Home page
D. N. Lakdawalla, D. P. Goldman, P.-C. Michaud, N. Sood, R. Lempert, Z. Cong, H. de Vries, and I. Gutierrez
U.S. Pharmaceutical Policy In A Global Marketplace
Health Aff., January 1, 2009; 28(1): w138 - w150.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K. R. Yabroff, C. J. Bradley, A. B. Mariotto, M. L. Brown, and E. J. Feuer
Estimates and Projections of Value of Life Lost From Cancer Deaths in the United States
J Natl Cancer Inst, December 17, 2008; 100(24): 1755 - 1762.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
C. N. Pellegrini, K. Lee, J. E. Olgin, M. P. Turakhia, Z. H. Tseng, R. Lee, N. Badhwar, B. Lee, and P. D. Varosy
Impact of advanced age on survival in patients with implantable cardioverter defibrillators
Europace, November 1, 2008; 10(11): 1296 - 1301.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
P. L. Hebert, J. E. Sisk, J. J. Wang, L. Tuzzio, J. M. Casabianca, M. R. Chassin, C. Horowitz, and M. A. McLaughlin
Cost-Effectiveness of Nurse-Led Disease Management for Heart Failure in an Ethnically Diverse Urban Community
Ann Intern Med, October 21, 2008; 149(8): 540 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
P. Blomstrom, M. Ekman, C. B. Lundqvist, M.J. Calvert, N. Freemantle, S. Lonnerholm, G. Wikstrom, and B; Jonsson
Cost effectiveness of cardiac resynchronization therapy in the Nordic region: An analysis based on the CARE-HF trial
Eur J Heart Fail, September 1, 2008; 10(9): 869 - 877.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
Y.-C. T. Shih and M. T. Halpern
Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?
CA Cancer J Clin, July 1, 2008; 58(4): 231 - 244.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. V. Pandharipande, D. A. Gervais, P. R. Mueller, C. Hur, and G. S. Gazelle
Radiofrequency Ablation versus Nephron-sparing Surgery for Small Unilateral Renal Cell Carcinoma: Cost-effectiveness Analysis
Radiology, July 1, 2008; 248(1): 169 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
D. H. Howard, D. Meltzer, C. Kollman, M. Maiers, B. Logan, L. Gragert, M. Setterholm, and M. M. Horowitz
Use of Cost-Effectiveness Analysis to Determine Inventory Size for a National Cord Blood Bank
Med Decis Making, March 1, 2008; 28(2): 243 - 253.
[Abstract] [PDF]

Home page
 PediatricsHome page
V. J. Flaherman, T. C. Porco, E. Marseille, and S. E. Royce
Cost-effectiveness of Alternative Strategies for Tuberculosis Screening Before Kindergarten Entry
Pediatrics, July 1, 2007; 120(1): 90 - 99.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
K. D. Frick, E. W. Gower, J. H. Kempen, and J. L. Wolff
Economic Impact of Visual Impairment and Blindness in the United States
Arch Ophthalmol, April 1, 2007; 125(4): 544 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Public HealthHome page
W. Brouwer, J. V. Exel, P. V. Baal, and J. Polder
Economics and public health: engaged to be happily married!
Eur J Public Health, April 1, 2007; 17(2): 122 - 123.
[Full Text] [PDF]

Home page
 CJASNHome page
D. Schon, S. W. Blume, K. Niebauer, C. S. Hollenbeak, and G. de Lissovoy
Increasing the Use of Arteriovenous Fistula in Hemodialysis: Economic Benefits and Economic Barriers
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 268 - 276.
[Abstract] [Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
A. B. Rosen, D. M. Cutler, D. M. Norton, H. M. Hu, and S. Vijan
The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002
Health Aff., January 1, 2007; 26(1): 111 - 123.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. R. Earnshaw, A. V. Joshi, M. R. Wilson, and J. Rosand
Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage
Stroke, November 1, 2006; 37(11): 2751 - 2758.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. S. Chan, S. Vijan, F. Morady, and H. Oral
Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2513 - 2520.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Zwanziger, W. J. Hall, A. W. Dick, H. Zhao, A. I. Mushlin, R. M. Hahn, H. Wang, M. L. Andrews, C. Mooney, H. Wang, et al.
The Cost Effectiveness of Implantable Cardioverter-Defibrillators: Results From the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2310 - 2318.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
N. T. Ayas, J. M. FitzGerald, J. A. Fleetham, D. P. White, M. Schulzer, C. F. Ryan, R. Ghaeli, G. W. Mercer, P. Cooper, M. C. Y. Tan, et al.
Cost-effectiveness of Continuous Positive Airway Pressure Therapy for Moderate to Severe Obstructive Sleep Apnea/Hypopnea.
Arch Intern Med, May 8, 2006; 166(9): 977 - 984.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. Feuchtbaum and G. Cunningham
Economic Evaluation of Tandem Mass Spectrometry Screening in California
Pediatrics, May 1, 2006; 117(5/S1): S280 - S286.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
C. M Bell, D. R Urbach, J. G Ray, A. Bayoumi, A. B Rosen, D. Greenberg, and P. J Neumann
Bias in published cost effectiveness studies: systematic review
BMJ, March 25, 2006; 332(7543): 699 - 703.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. S. Van Howe and L. P. Kusnier II
Diagnosis and Management of Pharyngitis in a Pediatric Population Based on Cost-Effectiveness and Projected Health Outcomes
Pediatrics, March 1, 2006; 117(3): 609 - 619.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
K D Frick and S M Kymes
The calculation and use of economic burden data.
Br. J. Ophthalmol., March 1, 2006; 90(3): 255 - 257.
[Full Text] [PDF]

Home page
 Med Decis MakingHome page
M. M. Byrne, K. O'Malley, and M. E. Suarez-Almazor
Willingness to Pay per Quality-Adjusted Life Year in a Study of Knee Osteoarthritis
Med Decis Making, November 1, 2005; 25(6): 655 - 666.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
J. T. King Jr., J. Tsevat, J. R. Lave, and M. S. Roberts
Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation
Med Decis Making, November 1, 2005; 25(6): 667 - 677.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
F. L. Lynch, M. Hornbrook, G. N. Clarke, N. Perrin, M. R. Polen, E. O'Connor, and J. Dickerson
Cost-effectiveness of an Intervention to Prevent Depression in At-Risk Teens
Arch Gen Psychiatry, November 1, 2005; 62(11): 1241 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
P. S. Jensen, J. A. Garcia, S. Glied, M. Crowe, M. Foster, M. Schlander, S. Hinshaw, B. Vitiello, L. E. Arnold, G. Elliott, et al.
Cost-Effectiveness of ADHD Treatments: Findings From the Multimodal Treatment Study of Children With ADHD
Am J Psychiatry, September 1, 2005; 162(9): 1628 - 1636.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. T. Schousboe, J. A. Nyman, R. L. Kane, and K. E. Ensrud
Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women
Ann Intern Med, May 3, 2005; 142(9): 734 - 741.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. G. M. Hunink
Decision Making in the Face of Uncertainty and Resource Constraints: Examples from Trauma Imaging
Radiology, May 1, 2005; 235(2): 375 - 383.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
T. E Delea, T. A Jacobson, P. W. Serruys, J. S Edelsberg, and G. Oster
Cost-Effectiveness of Fluvastatin Following Successful First Percutaneous Coronary Intervention
Ann. Pharmacother., April 1, 2005; 39(4): 610 - 616.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. Avorn and W. C. Winkelmayer
Comparing the Costs, Risks, and Benefits of Competing Strategies for the Primary Prevention of Venous Thromboembolism
Circulation, December 14, 2004; 110(24_suppl_1): IV-25 - IV-32.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
G. Nichol, P. Kaul, E. Huszti, and J. F.P. Bridges
Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure
Ann Intern Med, September 7, 2004; 141(5): 343 - 351.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
D. M. Kent, A. M. Fendrick, and K. M. Langa
New and Dis-Improved: On the Evaluation and Use of Less Effective, Less Expensive Medical Interventions
Med Decis Making, June 1, 2004; 24(3): 281 - 286.
[Abstract] [PDF]

Home page
 JAMAHome page
L. E. Boulware, B. G. Jaar, M. E. Tarver-Carr, F. L. Brancati, and N. R. Powe
Screening for Proteinuria in US Adults: A Cost-effectiveness Analysis
JAMA, December 17, 2003; 290(23): 3101 - 3114.
[Abstract] [Full Text] [PDF]

Home page
 GerontologistHome page
W. G. Weissert, R. A. Hirth, M. E. Chernew, S. Diwan, and J. Kim
Case Management: Effects of Improved Risk and Value Information
Gerontologist, December 1, 2003; 43(6): 797 - 805.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
R. C. Carlos, D. A. Axelrod, J. H. Ellis, P. H. Abrahamse, and A. M. Fendrick
Incorporating Patient-Centered Outcomes in the Analysis of Cost-Effectiveness: Imaging Strategies for Renovascular Hypertension
Am. J. Roentgenol., December 1, 2003; 181(6): 1653 - 1661.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Nichol, T. Valenzuela, D. Roe, L. Clark, E. Huszti, and G.A. Wells
Cost Effectiveness of Defibrillation by Targeted Responders in Public Settings
Circulation, August 12, 2003; 108(6): 697 - 703.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
P. A. Ubel, R. A. Hirth, M. E. Chernew, and A. M. Fendrick
What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?
Arch Intern Med, July 28, 2003; 163(14): 1637 - 1641.
[Full Text] [PDF]

Home page
 RadiologyHome page
K. Visser, M. C. J. M. Kock, K. M. Kuntz, M. C. Donaldson, G. S. Gazelle, and M. G. Myriam Hunink
Cost-effectiveness Targets for Multi-Detector Row CT Angiography in the Work-up of Patients with Intermittent Claudication
Radiology, June 1, 2003; 227(3): 647 - 656.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. D. Malkin, E. Keeler, M. S. Broder, and S. Garber
Postpartum Length of Stay and Newborn Health: A Cost-Effectiveness Analysis
Pediatrics, April 1, 2003; 111(4): e316 - 322.
[Abstract] [Full Text] [PDF]

Home page
 Sex. Transm. Infect.Home page
D N Fisman, E W Hook III, and S J Goldie
Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2
Sex Transm Inf, February 1, 2003; 79(1): 45 - 52.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
Y. S. Liem, M. C. J. M. Kock, J. N. M. Ijzermans, W. Weimar, K. Visser, and M.G. M. Hunink
Living Renal Donors: Optimizing the Imaging Strategy--Decision- and Cost-effectiveness Analysis
Radiology, January 1, 2003; 226(1): 53 - 62.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. M. Egan
QALYs or quackery? The quagmire of quantifying the cost of breathing
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 406 - 408.
[Full Text] [PDF]

Home page
 Journal of Health Politics, Policy and LawHome page
P. D. Jacobson and M. L. Kanna
Cost-Effectiveness Analysis in the Courts: Recent Trends and Future Prospects
Journal of Health Politics Policy and Law, April 1, 2001; 26(2): 291 - 326.
[Abstract] [PDF]